OSU molecular geneticist wins NSF award for most promising young scientists

Ohio State Universty Assistant Professor of Molecular Genetics Keith Slotkin has received the National Science Foundation’s highest award for the country’s most promising young scientists, the NSF CAREER Award.

These grants are given to researchers who early in their careers have clearly demonstrated their potential for making significant discoveries in their fields. Slotkin studies transposable elements, sometimes called “jumping genes,” that are stretches of DNA that can duplicate or move from one location in the genome to another.

“These are fragments of DNA that reside in the genomes of multicellular organisms,” Slotkin said. “They’re not considered actual genes, but they’re like little genomic parasites. They are out only to duplicate themselves—not to help the organism they reside in.”

Their highly-successful ability to do just that has resulted in transposable elements occupying vast amounts of most plant and animal genomes. “For example, they occupy nearly half of the human genome, and 85% of corn,” Slotkin said.

Although often overlooked or dismissed as “junk DNA,” transposable elements have played an important role in the structure and evolution of these genomes.

One of the key questions is why transposable elements have been conserved through time.

“Maybe,” Slotkin said, “they have a key function in the organism. But we don’t yet know whether they are pure parasites or have another function.

“But we do know that when transposable elements are active—that is when they ‘jump,’ they cause damage, which includes chromosome breakage, instability, and disease and can destroy an organism very quickly from inside.”

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

43North competition awards OSU student’s Genetesis $260K and People’s Choice award | Columbus Business First, October 31, 2014

New study shows combining GanedenBC30 with prebiotics provides digestive health benefits | Ganeden, October 30, 2014

Charles River acquires ChanTest for up to $54M | GEN, October 30, 2014

Ashland Specialty Ingredients launches web-based film-coatings troubleshooting tool and new pharmaceutical excipients website | PR Web, October 30, 2014

IBM and Cleveland Clinic use Watson to advance genomic research for cancer care pilot | PR Newswire, October 29, 2014

Cleveland Clinic announces Top Ten medical innovations for 2015, mobile stroke unit and Dengue vaccine top list (video) | Cleveland.com, October 29, 2014

Ampersand Capital Partners exits ChanTest investment with sale to Charles River Laboratories | PR Newswire, October 29, 2014

Camargo Pharmaceutical Services meets growing client needs with appointment of industry leader Steven Castillo as Vice President Of Drug Development | BioSpace, October 29, 2014

Scientific breakthrough at Cincinnati Children’s Hospital Medical Center could help battle cancer, ulcers | Cincinnati Business Courier, October 29, 2014

Devicor Medical Products of Sharonville, Ohio acquired by Danaher Corporation’s Leica Biosystems | Cincinnati.com, October 28, 2014

GTCR announces sale of Devicor Medical Products to Danaher Corporation’s Leica Biosystems | Business Wire, October 28, 2014

Researchers at Cincinnati Children’s Hospital Medical Center studying how to create replacement organs for people who need transplants | Cincinnati Business Courier, October 28, 2014

Juventas Therapeutics strengthens management team with new senior vice president of finance and operations, Troy Ignelzi | PR Newswire, October 28, 2014

Enable Injections signs strategic development agreement with CSL Behring to market novel drug delivery device | Philadelphia Business Journal, October 28, 2014

Ohio’s 2014 Bioproduct World Conference names Magic Dirt of Little Rock, Arkansas the Bioproduct Innovation of the Year | Wisconsin State Farmer, October 28, 2014

Ohio Soybean Council Foundation offers $36,000 in scholarships, majors include biotechnology | Ohio Soybean Council Foundation, October 28, 2014

Danaher’s Leica Biosystems division agrees to buy Devicor Medical Products, a developer of breast biopsy products | MASS Device, October 28, 2014

University Hospitals selects GenomOncology’s GO Clinical Workbench to launch their first NGS-based cancer diagnostic test | PR Newswire, October 27, 2014

INC Research of Raleigh, NC and the former Kendle location in Cincinnati, OH, plans IPO of up to $156M | Triangle Business Journal, October 27, 2014

NASA Glenn Research Center’s new office building is an example of continued commitment to Brook Park | Cleveland.com, October 27, 2014